StockNews.com assumed coverage on shares of VBI Vaccines (NASDAQ:VBIV – Free Report) in a report released on Saturday. The firm issued a sell rating on the biopharmaceutical company’s stock.
VBI Vaccines Stock Performance
Shares of VBIV stock opened at $0.60 on Friday. The company has a market capitalization of $17.27 million, a price-to-earnings ratio of -0.05 and a beta of 1.90. VBI Vaccines has a one year low of $0.45 and a one year high of $3.47. The company’s 50-day moving average is $0.61 and its 200 day moving average is $0.61.
VBI Vaccines Company Profile
Read More
- Five stocks we like better than VBI Vaccines
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Garmin Navigates to New Highs Driven By Wearables Trend
- What is a Stock Market Index and How Do You Use Them?
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- Are Penny Stocks a Good Fit for Your Portfolio?
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for VBI Vaccines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VBI Vaccines and related companies with MarketBeat.com's FREE daily email newsletter.